CLINICAL TRIALS PROFILE FOR LOKELMA
✉ Email this page to a colleague
All Clinical Trials for Lokelma
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT04063930 ↗ | The Effect of Sodium Zirconium Cyclosilicate on Albuminuria in Patients With Type 2 Diabetes and Hyperkalemia | Recruiting | AstraZeneca | Phase 4 | 2019-10-01 | To investigate whether concomitant treatment with Lokelma can improve the efficacy of standard blockade of the renin-angiotensin system in patients with type 2 diabetes, diabetic nephropathy and hyperkalemia. |
NCT04063930 ↗ | The Effect of Sodium Zirconium Cyclosilicate on Albuminuria in Patients With Type 2 Diabetes and Hyperkalemia | Recruiting | Zealand University Hospital | Phase 4 | 2019-10-01 | To investigate whether concomitant treatment with Lokelma can improve the efficacy of standard blockade of the renin-angiotensin system in patients with type 2 diabetes, diabetic nephropathy and hyperkalemia. |
NCT04063930 ↗ | The Effect of Sodium Zirconium Cyclosilicate on Albuminuria in Patients With Type 2 Diabetes and Hyperkalemia | Recruiting | Steno Diabetes Center Copenhagen | Phase 4 | 2019-10-01 | To investigate whether concomitant treatment with Lokelma can improve the efficacy of standard blockade of the renin-angiotensin system in patients with type 2 diabetes, diabetic nephropathy and hyperkalemia. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Lokelma
Condition Name
Clinical Trial Locations for Lokelma
Trials by Country
Clinical Trial Progress for Lokelma
Clinical Trial Phase
Clinical Trial Sponsors for Lokelma
Sponsor Name